Transesophageal Echocardiography (TEE) stands out as a sophisticated medical imaging method designed to offer detailed insights into the heart's intricacies through the use of high-frequency sound waves. In contrast to conventional echocardiography, TEE involves the insertion of a small ultrasound transducer into the esophagus, enabling a closer and clearer visualization of the heart's structures. This technique becomes particularly valuable when a more thorough examination of the heart is warranted, especially in cases involving ambiguous or intricate cardiac conditions. The versatility of TEE becomes evident in its ability to assess heart valve function with precision, identify the presence of blood clots or masses within the heart chambers, and provide a comprehensive evaluation of the heart's overall anatomy. This imaging modality finds frequent application in surgical settings, notably during cardiac surgeries, where it serves as an invaluable tool to guide surgeons in executing precise interventions. By offering real-time and high-resolution images, TEE contributes significantly to enhancing the accuracy of surgical procedures and decision-making processes.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States